ArticleJournal of immunology (Baltimore, Md. : 1950)2023

Combination CTLA4Ig and Anti-CD40 Ligand Treatment Modifies T and B Cell Metabolic Profiles and Promotes B Cell Receptor Remodeling in a Mouse Model of Systemic Lupus Erythematosus.

Chirag Raparia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.